Phoenix Clinical Inc

Cairn Biosciences is a San Francisco-based biotech company that specializes in discovering new medicines by mapping multiscale cell dynamics. Their proprietary COMPASS discovery platform utilizes innovative simulations of living biology to navigate complex disease biology and unlock exclusive routes to novel targets and drugs, with a focus on overcoming acquired resistance to targeted cancer therapies. With a diverse and multidisciplinary team of experts in drug discovery, disease biology, engineering, and computation, Cairn Biosciences is pioneering a new drug discovery paradigm. Their team, led by established biopharma leader and serial drug discovery innovator Mary Ludlam, is dedicated to delivering better therapeutics through their expertise in synthetic cell biology, high-throughput microscopy, computational analysis, and more.Generated from the website

Marin Biologic Laboratories is a contract research organization that provides custom research and development as well as GLP and GMP compliant assay development and validation and testing services for the pharmaceutical, biotechnology, diagnostic and agricultural industries. The company blends the fields of cell biology, immunology, molecular biology and biochemistry to tackle complex projects. Based upon its cell culture and tissue culture experiences, the company specializes in cell-based assays and bioassays and can utilize its experience for testing a wide variety of drugs. The company can take a clients molecule and develop rare monoclonal antibodies for subsequent assay development. The company can also optimize protein production and produce antibodies up to one gram per week. Marin Biologic has extensive experience in cell culture and can perform a variety of assays involved with drug action such as apotosis, cell growth and cytotoxicity assays. Marin Biologic Laboratories is headquartered in Tiburon, Calif.

The Smith-Kettlewell Eye Research Institute (SKERI) is a nonprofit independent research institute located in San Francisco, dedicated to advancing research in vision science since 1960. Its mission is to enhance the understanding of normal vision and develop diagnostic procedures and treatments for visual disorders, while also focusing on rehabilitation techniques for the blind and partially sighted. SKERI is actively involved in various research projects, with a particular emphasis on low vision rehabilitation and the development of assistive technologies. The institute encourages community participation through internships and volunteer opportunities, fostering a collaborative environment aimed at making a significant impact in the field of vision science. Generated from the website